baha the information company baha WebStation Terminal contact us Request free demo

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Free License - non-commercial use only

Region

Time Zone

International
history
open
Sign Up / Login

For full-featured experience, please enable JavaScript.

BVT Aktienanleihe EVT 31.12.2024/ DE000VM501Z4 /

2024-05-24 9:45:57 AM	Chg.-2.63	Bid9:59:39 PM	Ask9:59:39 PM	Underlying	Strike price	Expiration date	Option type
54.66EUR	-4.59%	- Bid Size: -	- Ask Size: -	EVOTEC SE INH O.N.	20.00 EUR	2024-12-31	Call

GlobeNewswire 05-14 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

GlobeNewswire 2023-12-11 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...

GlobeNewswire 2023-11-07 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

GlobeNewswire 2020-08-20 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

GlobeNewswire 2019-02-07 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 2019-02-07 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 2018-02-15 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

GlobeNewswire 2018-01-08 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

GlobeNewswire 2017-09-14 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO

GlobeNewswire 2011-11-29 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 2011-11-10 Evotec reports nine months results: Upside materialising

GlobeNewswire 2011-11-03 Evotec to Report Third Quarter Results on 10 November 2011

GlobeNewswire 2011-10-27 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi

GlobeNewswire 2011-10-20 Evotec and APEIRON Biologics start next project on the Cbl-b target

GlobeNewswire 2011-10-05 Evotec announces second multi-target collaboration with UCB

GlobeNewswire 2011-09-29 Evotec acquires remaining 30% of Indian Joint Venture from DIL

GlobeNewswire 2011-09-09 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 2011-09-05 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease

GlobeNewswire 2011-09-05 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...

GlobeNewswire 2011-08-18 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...

GlobeNewswire 2011-08-11 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised

GlobeNewswire 2011-08-11 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company

GlobeNewswire 2011-08-04 Evotec to Report Second Quarter 2011 Results on 11 August 2011

GlobeNewswire 2011-07-07 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases

GlobeNewswire 2011-06-30 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...